Leonard, Street and Deinard is representing MEDTOX Scientific, Inc. (NASDAQ: MTOX), a provider of forensic and clinical laboratory services, in the proposed acquisition by Laboratory Corporation of America Holdings (NYSE: LH) for approximately $240 million in cash.

“We are honored to be advising MEDTOX in this important transaction” said Leonard, Street and Deinard shareholder Stephen M. Quinlivan.

The transaction is subject to customary closing conditions, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and approval by MEDTOX’s stockholders.

Leonard, Street and Deinard is serving as MEDTOX’s legal advisor. The attorney team, led by Stephen M. Quinlivan, includes Thomas L. Osteraas, Joshua A. Bobich and Nicole H. Strydom (corporate/M&A); Jeffrey P. Cairns (employee benefits); Sheva J. Sanders (health care); David N. Haynes (tax); and William L. Greene and Tom A. Jensen (Hart-Scott-Rodino).